Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Assessing the role of PTEN deletion in Cholinergic Neurons on Kupffer Cells in Non-Alcoholic Steatohepatitis
FY 2021-22
Summary
Non-Alcoholic Fatty Liver Disease (NAFLD) is a spectrum of liver diseases, of which an advanced form is called non-alcoholic steatohepatitis (NASH). Due to a combination of sedentary lifestyles and calorie rich diets in developed countries, NASH is becoming more prevalent and severe with increasingly higher number of cases being reported each year. Currently, there are limited treatment options for patients suffering from NASH which highlights the importance of looking into the exact mechanisms behind NASH progression. Immune cells in the liver play a key role in worsening NASH to stages that cause irreversible liver damage. They do this by attacking liver cells and creating scar tissue. Numerous studies have found these immune cells can be inactivated by activating specific nerves that run through the liver. They do this by releasing chemical signals which bind to liver immune cells and inactivate them. Our research has found these nerves are activated when we turn off a gene called PTEN. The goal of our project is to determine what effect turning off PTEN will have on immune cells in a liver affected by NASH. Our expectations are that we can turn off harmful immune cells in the liver by turning off PTEN, since this is known to activate nerves that inactivate harmful immune cells in the liver. This project is expected to improve our understanding of the way the brain controls harmful immune cells in patients suffering from NASH and to provide us with new ways of controlling immune cells in NASH patients to improve treatment outcomes.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466491
Name
Abdul Razzaq Faisal
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Assessing the role of PTEN deletion in Cholinergic Neurons on Kupffer Cells in Non-Alcoholic Steatohepatitis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
A7 Nicotinic Acetylcholine Receptors (A7nachrs); Animal Models Of Nash; Chronic Inflammation; Immunology; Kupffer Cells; Liver; Non-Alcoholic Fatty Liver Disease (Nafld); Non-Alcoholic Steatohepatitis (Nash); Phosphate And Tensin Homolog (Pten); Vagal Nerve Activity (Vna)
Abstract
Non-Alcoholic Fatty Liver Disease (NAFLD) is a spectrum of liver diseases, of which an advanced form is called non-alcoholic steatohepatitis (NASH). Due to a combination of sedentary lifestyles and calorie rich diets in developed countries, NASH is becoming more prevalent and severe with increasingly higher number of cases being reported each year. Currently, there are limited treatment options for patients suffering from NASH which highlights the importance of looking into the exact mechanisms behind NASH progression. Immune cells in the liver play a key role in worsening NASH to stages that cause irreversible liver damage. They do this by attacking liver cells and creating scar tissue. Numerous studies have found these immune cells can be inactivated by activating specific nerves that run through the liver. They do this by releasing chemical signals which bind to liver immune cells and inactivate them. Our research has found these nerves are activated when we turn off a gene called PTEN. The goal of our project is to determine what effect turning off PTEN will have on immune cells in a liver affected by NASH. Our expectations are that we can turn off harmful immune cells in the liver by turning off PTEN, since this is known to activate nerves that inactivate harmful immune cells in the liver. This project is expected to improve our understanding of the way the brain controls harmful immune cells in patients suffering from NASH and to provide us with new ways of controlling immune cells in NASH patients to improve treatment outcomes.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Abdul Razzaq, Faisal
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~